Skip to main content

Faculty Profile

jo-jinheeJinhee Jo

Research Assistant Professor
Department of Pharmacy Practice and Translational Research

Office: 
University of Houston College of Pharmacy
Health 2, Room 3044
4349 Martin Luther King Boulevard
Houston, TX 77204

Contact: jjo2@uh.edu

Research:

  • Clostridioides difficile infection
  • Host microbiome colonization resistance against bacterial pathogens including C. difficile and other multidrug resistant organisms
  • Antimicrobial resistance
  • Board Certified Infectious Diseases Pharmacist (BCIDP), Board of Pharmacy Specialties
  • Postdoctoral Infectious Diseases Fellowship – The University of Houston College of Pharmacy
  • PGY-1 Pharmacy Residency, ASHP Accredited, CHI Baylor St. Luke’s Medical Center
  • Doctor of Pharmacy, with Honors, University of Illinois at Chicago College of Pharmacy
  • B.S. in Biology, Wheaton College

Publications

Google Scholar Profile
  • Hengel RL, Schroeder CP, Jo J, Ritter TE, Nathan RV, Gonzales-Luna AJ, Obi EN, Dilon R, Van Angelen, LJ, Garey KW. Recurrent Clostridioides difficile Infection Worsens Anxiety-Related Patient-Reported Quality of Life. J Patient Rep Outcomes 2022;6(1):49.
  • Jo J, Gonzales-Luna AJ, Lancaster CK, McPherson JK, Begum K, Alam MJ, Garey KW. Multi-country Surveillance of Clostridioides difficile Demonstrates High Prevalence of Spores in Non-Healthcare Environmental Settings. Anaerobe. 2022; 75:102543.
  • Garey KW, McPherson J, Dinh AQ, Hu C, Jo J, Wang W, Lancaster CK, Gonzales-Luna AJ, Loveall C, Begum K, Alam MJ, Silverman MH, Hanson B. Efficacy, Safety, Pharmacokinetics, and Microbiome Changes of Ibezapolstat in Adults with Clostridioides difficile Infection: A Phase 2a Multicenter Clinical Trial. Clin Infect Dis. 2022; [Online ahead of print]..
  • Alosaimy S. Lagnf AM, Morrisette T, Scipione MR, Zhao JJ, Jorgensen SCJ, Mynatt R, Carlson TJ, Jo J, Garey KW, Allen D, DeRonde K, Vega AD, Abbo LM, Venugopalan V, Athans V, Saw S, Claeys KC, Miller M, Molina KC, Veve M, Kufel WD, Amaya L, Yost C, Ortwine J, Davis SL, Rybak MJ. Real-world, Multi-center Experience with Meropenem-Vaborbactam for Gram-Negative Bacterial Infections including Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa. Open Forum Infect Dis. 2021;14;8(8): ofab371.
  • Jo J, Tran TT, Beyda ND, Simmons D, Hendrickson J, Almutairi MS, Alnezary FS, Gonzales-Luna AJ, Septimus EJ, Garey KW. Development of the Invasive Candidiasis Discharge [I Can Discharge] Model, a Mixed Method Analysis. (Submitted March 2022)..
  • Cao Y, Wang L, Kelly CP, Pollock NR, Galvez JAV, Garey KW, Jo J, Daugherty K, Xu H, Yao J, Chen Y, Chen X. Serum Metabolic Biomarkers Distinguish Clostridioides difficile Infection from Asymptomatic Carriage. (Submitted April 2022).

Posters and Abstracts

  • Jo J, Hu C, Gonzales-Luna AJ, Lancaster C, Garey KW. Bile Acid Concentrations in Healthy Volunteers Receiving Oral Omadacycline or Vancomycin. Poster# TBD. IDWeek, Washington, DC. Oct 19-23, 2022.
  • Jo J, McPherson JM, Gonzales-Luna AJ, Lancaster C, Garey KW. Pharmacokinetic-Pharmacodynamic Analysis of Oral Vancomycin and Gut Microbiome Changes in Healthy Volunteers: An Exploratory Study. Poster# TBD. IDWeek, Washington, DC. Oct 19-23, 2022.
  • Jo J, Hu C, Gonzales-Luna AJ, Lancaster C, Garey KW. A Pharmacokinetic Analysis of Oral Vancomycin Fecal Concentrations in Healthy Volunteers. Poster#54. MAD-ID Annual Meeting, Orlando, Florida. May 18-21, 2022.
  • Jo J, Hendrickson JA, Almutairi MS, Alnezary FS, Gonzales-Luna AJ, Tran CT, Beyda ND, Garey KW. A Multicenter Pharmacoepidemiologic Evaluation of Echinocandin Use. Poster#02816. 31st ECCMID, Virtual. July 9-12, 2021.
  • Jo J, Hendrickson JA, Almutairi MS, Alnezary FS, Beyda ND, Gonzales-Luna AJ, Tran CT, Simmons D, Garey KW. A Multicenter, Mixed-Method Evaluation of Delayed Hospital Discharge in Patients with Invasive Candidiasis receiving Echinocandins. Poster#157. IDWeek, Virtual. September 29-October 3, 2021.
  • Jo J, Hendrickson JA, Gonzales-Luna AJ, Beyda ND, Tran CT, Garey KW. A Multicenter harmacoepidemiologic Evaluation of Echinocandin Use. Poster#33. 4th Annual Texas Medical enter Antimicrobial Resistance and Stewardship Conference, Virtual. January 26-28, 2021.
  • Kuo J, Carlson TJ, Begum K, Jo J, Lancaster C, Alam MJ, Gonzales-Luna AJ, Garey KW. Epidemiologic of Carbapenem-Resistant Enterobacteriaceae in a Large Teaching Hospital in Houston, Texas. Poster#57. 4th Annual Texas Medical Center Antimicrobial Resistance and Stewardship Conference, Virtual. January 26-28, 2021.

Oral Presentations

  • "Global Surveillance of Clostridioides difficile Demonstrates High Prevalence in Non-Healthcare Settings," Selected for Oral Abstract at IDWeek 2021, Virtual; Featured in IDWeek News, Healio News, MedPage Today, Scitechdaily Health News, McKnights Clinical Daily News
  • "A Single-Center Surveillance Study of Cystic Fibrosis Microbiological Cultures," Selected for Rapid Fire Talk at 3rd Annual Texas Medical Center Antimicrobial Resistance Research and Stewardship Conference

Awards & Honors

  • IDWeek Trainee Award, October 2020, 2021, 2022
  • Dean’s List: UIC College of Pharmacy Fall 2017, Spring 2018
  • Dean’s List: Wheaton College Spring, Fall 2012, Spring 2013

Involvement

  • European Society of Clinical Microbiology and Infectious Diseases (ESCMID), 2021-present
  • Society of Infectious Diseases Pharmacists (SIDP), 2020-present
  • American College of Clinical Pharmacy (ACCP) – Infectious Diseases PRN, 2020-present
  • Texas Society of Health System Pharmacists (TSHP), 2019-2020
  • American Society of Health-System Pharmacists (ASHP), 2017-2019
  • American Pharmacists Association (APhA), 2014-2018